Ilaria Pennacchia

Anatomia Patologica - Azienda Ospedaliera S. Camillo Forlanini, Rome, Italy.

40 publications 2008 – 2021 ORCID

What does Ilaria Pennacchia research?

Ilaria Pennacchia studies mucormycosis, a dangerous fungal infection that can spread rapidly through the body, particularly affecting individuals with compromised immune systems. She specifically looks at how this infection can lead to haemophagocytic syndrome, a condition where the immune system mistakenly attacks healthy blood cells. This research is vital for understanding how severe fungal infections can complicate the health of vulnerable patients, helping medical professionals improve treatments and patient care.

Key findings

  • Reported a unique case of a 32-year-old man who developed haemophagocytic syndrome due to mucormycosis, marking only the second documented case of this connection.
  • Provided evidence that patients with weakened immune systems are at an increased risk for severe complications from mucormycosis.
  • Highlighted the importance of early diagnosis and treatment for preventing life-threatening outcomes in patients affected by these infections.

Frequently asked questions

Does Dr. Pennacchia study mucormycosis?
Yes, she focuses on mucormycosis, specifically how it affects patients with weakened immune systems.
What treatments has Dr. Pennacchia researched for mucormycosis?
Her research emphasizes the importance of early diagnosis and appropriate treatment to manage severe complications from mucormycosis.
Is Dr. Pennacchia's work relevant to patients with weakened immune systems?
Yes, her studies are crucial for understanding how to better treat patients with compromised immune systems who are susceptible to severe fungal infections.

Publications in plain English

A case of fatal embolization during laser lithotripsy.

2021

International journal of legal medicine

Farì G, Vecchio E, Oliva A, Silvestri N, Dell'Aquila M +3 more

Plain English
This study describes a rare case where a 43-year-old woman, who was paralyzed from the neck down, died during a procedure to remove kidney stones using lasers. After the procedure began, she experienced sudden heart issues and low oxygen levels, which led to a cardiac arrest despite emergency help. An autopsy revealed that small pieces of the kidney stones had traveled to her lungs and heart, causing her death, showing that such complications can happen unexpectedly during this type of surgery. Who this helps: This information helps doctors by highlighting the risks of laser lithotripsy and the need for careful monitoring during the procedure.

PubMed

Right sinus of Valsalva aneurysm.

2020

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology

Farì G, Pennacchia I, Stigliano E, Oliva A, Carbone A +1 more

Plain English
This study looked at a rare condition called right sinus of Valsalva aneurysm (SVA), which involves a weak spot in the aorta that can lead to a bulge. The researchers found a case in a 58-year-old homeless man who had a large aneurysm over 4 centimeters, which likely contributed to his death due to a heart rhythm problem. Understanding SVA is important because, while it is uncommon, it can have serious consequences, especially in vulnerable populations. Who this helps: This helps healthcare providers and patients with heart conditions recognize potential risks of aneurysms.

PubMed

Sudden death by massive systemic embolism from cardiac myxoma. Role of the clinical autopsy and review of literature.

2020

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology

Dell'Aquila M, Carbone A, Pennacchia I, Stigliano E, Oliva A +1 more

Plain English
This study looked at a rare type of heart tumor called a cardiac myxoma and its potential to cause sudden death through blood clots. The researchers reported a specific case where a person died suddenly from a large blood clot caused by this tumor and reviewed other documented cases, emphasizing the importance of recognizing these tumors for better treatment. Understanding how often these tumors occur and why they happen can help improve patient care, especially since many people with these tumors don't show any symptoms. Who this helps: Patients with cardiac myxomas, doctors, and families at risk of familial forms of the tumor.

PubMed

ER-/PR+/HER2- breast cancer type shows the highest proliferative activity among all other combined phenotypes and is more common in young patients: Experience with 6643 breast cancer cases.

2019

The breast journal

Arena V, Pennacchia I, Vecchio FM, Carbone A

Plain English
This study looked at different types of breast cancer to see how quickly they grow, focusing specifically on a less common subtype that is positive for progesterone receptors but negative for estrogen and HER2 receptors (called ER-/PR+/HER2-). Out of 6,643 breast cancer cases, this subtype, which makes up only 1.3% of cases, showed significantly higher growth rates compared to other types, indicating it tends to be more aggressive. Understanding this helps doctors identify and treat patients with this specific and fast-growing type of breast cancer more effectively. Who this helps: This research benefits patients diagnosed with ER-/PR+/HER2- breast cancer and their doctors.

PubMed

A case of miliaris osteoma cutis in a male: Dermoscopic findings and microablation treatment.

2019

Dermatologic therapy

Moro F, Ricci F, Pennacchia I, Mazzanti C, Abeni D +1 more

PubMed

Microscopic Extraovarian Sex Cord Proliferations: Report of the Seventh Case With 2 Year Follow-up.

2018

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists

Pennacchia I, Arena V, Federico F, Zannoni GF

PubMed

Fibroblastic connective tissue nevus: Clinicopathological and immunohistochemical study of 14 cases.

2017

Journal of cutaneous pathology

Pennacchia I, Kutzner H, Kazakov DV, Mentzel T

Plain English
This study looked at 14 cases of a rare skin condition called fibroblastic connective tissue nevus (FCTN), which typically appears as small lumps on the skin. The researchers found that most patients were between 1 and 56 years old, and none of the cases returned after treatment, regardless of whether the growths were fully removed. This is important because it helps doctors better identify and treat these benign skin lesions without worrying about them spreading. Who this helps: Patients with fibroblastic connective tissue nevus and their healthcare providers.

PubMed

Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL): a possible pathogenic role in chronic plaque psoriasis.

2016

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia

Caldarola G, Carbone A, Arena V, Pennacchia I, De Waure C +8 more

Plain English
This study examined a protein called TRAIL and its role in chronic plaque psoriasis, a skin condition. Researchers found that TRAIL and its receptors were significantly increased in the affected skin of 24 patients compared to healthy skin, indicating that TRAIL might contribute to the inflammation seen in psoriasis. Understanding TRAIL's involvement could lead to better treatments for managing this condition. Who this helps: Patients with chronic plaque psoriasis.

PubMed

Giant "turtle-egg tumors": a forgotten complication of quinine injections.

2016

Internal and emergency medicine

Mirijello A, Pacilli M, Pennacchia I, Manfrini A, Pacilli G

PubMed

YB-1 in breast cancer. Our laboratory data.

2016

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Arena V, Riccardi M, Pennacchia I, Franceschini G, Di Leone A +1 more

PubMed

Endometriosis-associated clear cell carcinoma arising in caesarean section scar: a case report and review of the literature.

2016

World journal of surgical oncology

Ferrandina G, Palluzzi E, Fanfani F, Gentileschi S, Valentini AL +4 more

Plain English
In this study, researchers followed a 44-year-old woman who developed clear cell endometrial carcinoma, a type of cancer, from endometriosis in her caesarean section scar. They found that the cancer had spread to lymph nodes, and despite treatment with chemotherapy and surgery, she unfortunately died two months after the diagnosis. This case highlights the importance of regularly checking for symptoms of endometriosis, especially in patients with a history of pelvic surgeries, as there can be serious health risks like cancer. Who this helps: This information benefits patients with a history of endometriosis and their doctors by raising awareness of potential complications.

PubMed

Linear and Bilateral Multinucleated Cell Angiohistiocytoma (MCAH).

2016

Journal of dermatological case reports

Coco V, Guerriero C, Di Stefani A, Pennacchia I, Peris K

Plain English
This study describes a rare skin condition called Multinucleated Cell Angiohistiocytoma (MCAH) in a 77-year-old woman who had red, itchy plaques on her legs. The case is unique because the skin lesions appeared in a specific, symmetrical pattern along the veins and were confirmed through detailed medical tests. Understanding MCAH is important because it helps doctors recognize and diagnose this rare disease, which has been reported in fewer than 100 cases since it was first identified in 1985. Who this helps: Patients with rare skin conditions and their doctors.

PubMed

HER2 immunohistochemical assessment with A0485 polyclonal antibody: is it time to refine the scoring criteria for the "2+" category?

2015

Applied immunohistochemistry & molecular morphology : AIMM

Pennacchia I, Vecchio FM, Carbone A, Arena V

Plain English
This research looked at how effectively a specific test (using a certain antibody) can identify HER2 status in breast cancer patients, which is crucial for determining who can benefit from specific treatments. Out of 943 cases studied, only 9 out of 86 cases with weak staining were found to have the gene amplified, compared to 19 out of 51 cases with strong staining, suggesting that combining the strength and continuity of the staining provides the best results for accurate testing. This matters because refining how we score HER2 tests could lead to better treatment decisions and outcomes for breast cancer patients. Who this helps: Patients with breast cancer who may benefit from HER2-targeting therapies.

PubMed

2013 ASCO/CAP updated guidelines for human epidermal growth factor receptor 2 testing: Impact on routine practice.

2015

Breast (Edinburgh, Scotland)

Pennacchia I, Carbone A, Di Cerbo A, Vecchio FM, Arena V

Plain English
This study looked at how new guidelines for testing a specific protein (HER2) in cancer patients impacted lab practices. After the new guidelines were put in place, testing for HER2 increased, with the number of in situ hybridization (ISH) tests rising significantly. This matters because clearer guidelines can help doctors make better treatment decisions for their patients, which could lead to improved outcomes. Who this helps: This helps patients with breast cancer by ensuring they receive more accurate testing and treatment options.

PubMed

The heme oxygenase/biliverdin reductase system in skin cancers.

2015

Journal of biological regulators and homeostatic agents

Arena V, Pennacchia I, Guerriero G, Mancuso C

Plain English
This study looked at specific proteins related to cell stress called the heme oxygenase/biliverdin reductase (HO/BVR) system in skin cancers. Researchers found that all nodular malignant melanoma samples showed strong presence of these proteins, while in basal cell carcinoma, 62% had HO-1 and 88% had HO-2. In contrast, benign skin lesions showed minimal presence of these proteins. This matters because identifying these proteins can help with the early diagnosis of skin cancers. Who this helps: This helps doctors in diagnosing skin cancers more effectively.

PubMed

HER2 status determination: analyzing the problems to find the solutions.

2015

Medicine

Terrenato I, Pennacchia I, Buglioni S, Mottolese M, Arena V

Plain English
This study looked at how accurately different hospitals determine HER2 status in breast cancer patients, which is crucial for treatment decisions. Researchers sent samples to 9 hospitals in Italy and found that hospitals generally agreed on HER2 scores of 0 and 3+, but struggled with scores of 1+ and 2+, showing agreement only 37% and 25% of the time, respectively. Improving how HER2 testing is done will help ensure patients receive the right treatment based on accurate diagnoses. Who this helps: This benefits patients with breast cancer and their doctors by ensuring better treatment options.

PubMed

Thyroglossal duct cyst cancer most likely arises from a thyroid gland remnant.

2014

Virchows Archiv : an international journal of pathology

Rossi ED, Martini M, Straccia P, Cocomazzi A, Pennacchia I +5 more

Plain English
This study investigated the rare occurrence of cancer in thyroglossal duct cysts (TDC), which happens in about 1.5% of cases. Researchers looked at 80 TDC samples and found that in 9 cases (11%), patients had papillary thyroid cancer. The results indicated that most of these cancers likely come from a leftover part of the thyroid gland rather than spreading from another thyroid cancer. Who this helps: Patients with thyroglossal duct cancers benefit from thorough thyroid evaluations to ensure proper management.

PubMed

Strong YB-1 expression predicts liver recurrence following resection for colorectal metastases.

2014

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Ardito F, Arena V, Vellone M, Grande G, Pennacchia I +5 more

Plain English
This study looked at a protein called YB-1 in patients who had liver surgery due to colon cancer that had spread to the liver. Researchers found that 74% of the patients had high levels of YB-1, and those with high levels faced a much higher chance of their cancer coming back in the liver after surgery—55% compared to 24% for those with low YB-1 levels. This matters because detecting high YB-1 levels can help doctors identify patients at greater risk for recurrence, enabling more targeted follow-up care. Who this helps: Patients with colorectal cancer that has spread to the liver.

PubMed

HER-2 intratumoral heterogeneity.

2013

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Arena V, Pennacchia I, Vecchio FM, Carbone A

PubMed

A tribute to Italian breast pathologists.

2013

International journal of surgical pathology

Arena V, Pennacchia I, Carbone A

PubMed

External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale.

2013

Journal of experimental & clinical cancer research : CR

Terrenato I, Arena V, Pizzamiglio S, Pennacchia I, Perracchio L +23 more

Plain English
This study looked at how accurately different pathology labs in the Lazio region of Italy determine HER2 levels in breast cancer samples, which is crucial for deciding treatment options. The researchers found that labs were very consistent in identifying the lowest (0) and highest (3+) HER2 scores, but had more difficulty with intermediate scores (1+ and 2+), with moderate agreement for 1+ and fair agreement for 2+. These results are important because they indicate that inconsistencies in interpreting these scores could affect patient treatment decisions, highlighting the need for better training and standardized procedures across labs. Who this helps: Patients with breast cancer needing accurate HER2 assessments for effective treatment.

PubMed

The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesions at histology: an institutional experience.

2013

European journal of endocrinology

Rossi ED, Martini M, Straccia P, Raffaelli M, Pennacchia I +4 more

Plain English
This study looked at a specific type of thyroid growth called oncocytic (or Hurthle) cell neoplasms to determine how often they turn out to be cancerous. Out of 150 cases studied, only 6% were found to be malignant, with the majority (94%) being benign adenomas. This shows that most oncocytic lesions are low-risk, which can help guide treatment decisions and avoid unnecessary surgeries. Who this helps: This benefits patients with oncocytic thyroid lesions by reducing the fear of cancer and the need for invasive procedures.

PubMed

Subcutaneous malignant melanoma of the scalp surgical flap after brain irradiation for anaplastic astrocytoma.

2012

Journal of neuro-oncology

Sturiale CL, Sabatino G, Albanese A, Balducci M, Lauriola L +2 more

PubMed

HER-2 in breast cancer: a puzzle's piece!

2012

International journal of surgical pathology

Arena V, Pennacchia I, Vecchio FM, Carbone A

PubMed

Primitive polypoid granular cell tumor.

2012

European journal of dermatology : EJD

Ricci F, Paradisi A, Silveri SL, Fossati B, Pennacchia I +3 more

PubMed

Morphological and molecular characteristics of nested melanoma of the elderly (evolved lentiginous melanoma).

2012

Virchows Archiv : an international journal of pathology

Pennacchia I, Garcovich S, Gasbarra R, Leone A, Arena V +1 more

Plain English
This study looked at a specific type of skin cancer called nested melanoma in older adults. The researchers observed that while these melanomas had patterns similar to benign moles, they had distinct features indicating they were cancerous, with tests showing that 7 out of 8 cases had abnormal chromosomes linked to melanoma. This is important because it helps doctors better identify and diagnose these cancers, which can sometimes be confused with harmless skin lesions. Who this helps: This helps patients and doctors in accurately diagnosing and treating melanoma.

PubMed

Diagnostic challenge of a proliferative nodule in a desmoplastic hairless hypopigmented nevus.

2012

European journal of dermatology : EJD

Bracaglia R, Tambasco D, Pennacchia I, D'Ettorre M, Gentileschi S +3 more

PubMed

Haemophagocytic syndrome associated with mucormycosis infection.

2012

International journal of immunopathology and pharmacology

Arena V, De-Giorgio F, Pennacchia I, Manna R, Vetrugno G +4 more

Plain English
This study looks at a severe fungal infection called mucormycosis, which can spread through the body and cause a condition where the immune system attacks its own blood cells, known as haemophagocytic syndrome (HS). They reported a case of a 32-year-old man who developed this syndrome due to the infection, marking only the second time this specific connection has been documented. This is important because it highlights a rare but serious complication of mucormycosis that can occur in people with weakened immune systems. Who this helps: This information is valuable for doctors treating patients with mucormycosis, especially those with compromised immune systems.

PubMed

Epithelioid hemangioendothelioma of the bone and intestinal infarction: an unusual association.

2011

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Arena V, Pennacchia I, Carbone A, Vecchio FM

PubMed

Chondroma of the hand with osteoid formation: first case report.

2011

International medical case reports journal

Arena V, Pennacchia I, Vecchio FM, Carbone A

Plain English
This research paper discusses a rare case of a chondroma, which is a type of benign tumor, found in the hand of a patient. This particular case is unique because it showed signs of osteoid formation, a substance normally related to developing bone. Recognizing such unusual features is important for understanding how these tumors can behave, which can help in diagnosing and treating them effectively. Who this helps: This benefits doctors and patients dealing with hand tumors.

PubMed

Polypoid Spitz nevus: two cases evaluated with genetic technique, prolonged follow up, and sentinel lymph node biopsy.

2011

Journal of cutaneous pathology

Pennacchia I, Gasbarra R, Manente L, Pisa R, Garcovich S +3 more

Plain English
This study looked at two cases of a skin growth called polypoid Spitz nevus, which can appear similar to more serious conditions like melanoma. Researchers followed the patients for a long time and used genetic testing to ensure these growths were not cancerous. They found that both cases were benign, meaning the patients have no signs of disease now and likely won't in the future, which is important because it helps distinguish between harmless and potentially dangerous skin lesions. Who this helps: Patients with skin growths and doctors diagnosing these conditions.

PubMed

"...And suddenly a tree!".

2011

International journal of surgical pathology

Arena V, Pennacchia I, Abenavoli L, Vecchio FM

PubMed

Aggressive large B-cell lymphoma in a systemic lupus erythematosus patient with chronic active Epstein-Barr virus infection: a case report.

2011

International journal of immunopathology and pharmacology

Abenavoli L, Pennacchia I, Stigliano E, Carbone A, Vecchio FM +1 more

Plain English
This study looked at a 49-year-old woman with systemic lupus erythematosus (SLE) who developed an aggressive type of cancer called diffuse large B-cell lymphoma (DLBCL) linked to a chronic infection with Epstein-Barr Virus (EBV). Unfortunately, she passed away shortly after being admitted to the hospital, and the examination of her tissues showed unusual growths consistent with DLBCL that were also connected to EBV. This research highlights the potential dangers for SLE patients and how EBV may play a role in the development of certain cancers. Who this helps: This helps patients with autoimmune diseases like SLE and their doctors by increasing awareness of cancer risks associated with EBV.

PubMed

Breast cancer classification: the dialogue is open.

2010

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Arena V, Pennacchia I, Monego G, Carbone A, Capelli A

PubMed

Breast cancer pathology report: in response to Zurrida et Al.

2010

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Arena V, Pennacchia I, Carbone A

PubMed

Fluorescent in situ hybridization as a primary test for HER2 status in breast cancer: controversies.

2010

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Arena V, Pennacchia I, Monego G, Carbone A, Capelli A

PubMed

"CISH the FISH" for HER2: our laboratory experience.

2010

American journal of clinical pathology

Arena V, Pennacchia I, Vecchio FM, Carbone A

PubMed

Fluorescent in situ hybridization for human epidermal growth factor receptor 2 assessment in breast cancer: is it applicable as a primary test?

2009

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Arena V, Pennacchia I, Carbone A, Capelli A

PubMed

Adult self-healing papular mucinosis on genital skin.

2009

Clinical and experimental dermatology

Feliciani C, Pennacchia I, Massi G

Plain English
This study looked at a rare skin condition called adult self-healing papular mucinosis, specifically on the genital area. The researchers found that the lesions, which were initially mistaken for a common infection, cleared up on their own within a few weeks. This finding is important because it highlights the need for accurate diagnosis to avoid unnecessary treatments and to differentiate this condition from sexually transmitted diseases. Who this helps: This helps patients experiencing skin issues and doctors diagnosing genital skin conditions.

PubMed

Sclerosing nevus with pseudomelanomatous features.

2008

Journal of cutaneous pathology

Fabrizi G, Pennacchia I, Pagliarello C, Massi G

Plain English
This study looked at a specific type of skin lesion called a sclerosing nevus, which has features that can resemble skin cancer but are actually benign. Researchers examined 19 cases and found that these lesions did not show signs of abnormal cell growth or spread, and none of the patients experienced recurrence or metastasis over time. This is important because it helps clarify that certain skin lesions can look concerning but are not cancerous, reducing unnecessary worry and treatments. Who this helps: Patients with skin lesions that may look suspicious but are actually benign.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.